321 related articles for article (PubMed ID: 17222320)
1. Low-dose naltrexone therapy improves active Crohn's disease.
Smith JP; Stock H; Bingaman S; Mauger D; Rogosnitzky M; Zagon IS
Am J Gastroenterol; 2007 Apr; 102(4):820-8. PubMed ID: 17222320
[TBL] [Abstract][Full Text] [Related]
2. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
[TBL] [Abstract][Full Text] [Related]
3. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
[TBL] [Abstract][Full Text] [Related]
4. The effects of infliximab maintenance therapy on health-related quality of life.
Feagan BG; Yan S; Bala M; Bao W; Lichtenstein GR
Am J Gastroenterol; 2003 Oct; 98(10):2232-8. PubMed ID: 14572573
[TBL] [Abstract][Full Text] [Related]
5. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.
Summers RW; Elliott DE; Qadir K; Urban JF; Thompson R; Weinstock JV
Am J Gastroenterol; 2003 Sep; 98(9):2034-41. PubMed ID: 14499784
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life during natalizumab maintenance therapy for Crohn's disease.
Feagan BG; Sandborn WJ; Hass S; Niecko T; White J
Am J Gastroenterol; 2007 Dec; 102(12):2737-46. PubMed ID: 18042106
[TBL] [Abstract][Full Text] [Related]
7. A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease.
Dotan I; Rachmilewitz D; Schreiber S; Eliakim R; van der Woude CJ; Kornbluth A; Buchman AL; Bar-Meir S; Bokemeyer B; Goldin E; Maaser C; Mahadevan U; Seidler U; Hoffman JC; Homoky D; Plasse T; Powers B; Rutgeerts P; Hommes D;
Gut; 2010 Jun; 59(6):760-6. PubMed ID: 20551461
[TBL] [Abstract][Full Text] [Related]
8. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
Folwaczny C; Wiebecke B; Loeschke K
Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024
[TBL] [Abstract][Full Text] [Related]
9. Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease.
Gelbmann CM; Rogler G; Gross V; Gierend M; Bregenzer N; Andus T; Schölmerich J
Am J Gastroenterol; 2002 Jun; 97(6):1438-45. PubMed ID: 12094862
[TBL] [Abstract][Full Text] [Related]
10. An open-labelled study of granulocyte colony-stimulating factor in the treatment of active Crohn's disease.
Korzenik JR; Dieckgraefe BK
Aliment Pharmacol Ther; 2005 Feb; 21(4):391-400. PubMed ID: 15709989
[TBL] [Abstract][Full Text] [Related]
11. Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study.
Hafer A; Krämer S; Duncker S; Krüger M; Manns MP; Bischoff SC
BMC Gastroenterol; 2007 Sep; 7():36. PubMed ID: 17784949
[TBL] [Abstract][Full Text] [Related]
12. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
Mantzaris GJ; Petraki K; Sfakianakis M; Archavlis E; Christidou A; Chadio-Iordanides H; Triadaphyllou G
Clin Gastroenterol Hepatol; 2003 Mar; 1(2):122-8. PubMed ID: 15017504
[TBL] [Abstract][Full Text] [Related]
13. Etanercept in the treatment of active refractory Crohn's disease: a single-center pilot trial.
D'Haens G; Swijsen C; Noman M; Lemmens L; Ceuppens J; Agbahiwe H; Geboes K; Rutgeerts P
Am J Gastroenterol; 2001 Sep; 96(9):2564-8. PubMed ID: 11569676
[TBL] [Abstract][Full Text] [Related]
14. Steroid-sparing properties of sargramostim in patients with corticosteroid-dependent Crohn's disease: a randomised, double-blind, placebo-controlled, phase 2 study.
Valentine JF; Fedorak RN; Feagan B; Fredlund P; Schmitt R; Ni P; Humphries TJ
Gut; 2009 Oct; 58(10):1354-62. PubMed ID: 19505878
[TBL] [Abstract][Full Text] [Related]
15. Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease.
Thia KT; Sandborn WJ; Lewis JD; Loftus EV; Feagan BG; Steinhart AH; Hanauer SB; Persson T; Sands BE
Am J Gastroenterol; 2008 Dec; 103(12):3123-31. PubMed ID: 18786111
[TBL] [Abstract][Full Text] [Related]
16. Infliximab (REMICADE) therapy in the treatment of pediatric Crohn's disease.
Baldassano R; Braegger CP; Escher JC; DeWoody K; Hendricks DF; Keenan GF; Winter HS
Am J Gastroenterol; 2003 Apr; 98(4):833-8. PubMed ID: 12738464
[TBL] [Abstract][Full Text] [Related]
17. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.
Hyams J; Crandall W; Kugathasan S; Griffiths A; Olson A; Johanns J; Liu G; Travers S; Heuschkel R; Markowitz J; Cohen S; Winter H; Veereman-Wauters G; Ferry G; Baldassano R;
Gastroenterology; 2007 Mar; 132(3):863-73; quiz 1165-6. PubMed ID: 17324398
[TBL] [Abstract][Full Text] [Related]
18. Long-term quality of life in patients with Crohn's disease and perianal fistulas: influence of fecal diversion.
Kasparek MS; Glatzle J; Temeltcheva T; Mueller MH; Koenigsrainer A; Kreis ME
Dis Colon Rectum; 2007 Dec; 50(12):2067-74. PubMed ID: 17680311
[TBL] [Abstract][Full Text] [Related]
19. Long-term management of Crohn's disease with mesalamine capsules (Pentasa). Pentasa Crohn's Disease Compassionate Use Study Group.
Hanauer SB; Krawitt EL; Robinson M; Rick GG; Safdi MA
Am J Gastroenterol; 1993 Sep; 88(9):1343-51. PubMed ID: 8362827
[TBL] [Abstract][Full Text] [Related]
20. A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy.
Forbes GM; Sturm MJ; Leong RW; Sparrow MP; Segarajasingam D; Cummins AG; Phillips M; Herrmann RP
Clin Gastroenterol Hepatol; 2014 Jan; 12(1):64-71. PubMed ID: 23872668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
